Original Webinar Date: 08/22/2023

The evolving landscape in precision oncology: key research findings from the 2023 ASCO Annual Meeting

Hear from Tempus moderators Dr. Ezra Cohen and Dr. Calvin Chao as they engage in a multi-disciplinary discussion around practice changing approaches to somatic and germline testing with Dr. Ramaswamy Govindan from Siteman Cancer Center and Dr. Cathy Handy Marshall from Johns Hopkins Medicine.
Speakers Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus

Calvin Chao, MD
Senior Vice President of Medical Affairs, Tempus

Dr. Ramaswamy Govindan
Professor of Medicine, Washington University in St. Louis, Siteman Cancer Center

Catherine Handy Marshall, MD, MPH
Assistant Professor of Oncology, Johns Hopkins Medicine

We discuss new research data on the potential benefits to tumor/normal matched testing as it relates to incidental germline findings, testing behaviors for NSCLC patients and the most recent findings from the PADA-1 Trial and how it may affect approaches to monitoring resistance mechanisms through liquid biopsy.

Related Content

View more